From biobanking to personalized prevention of obesity, diabetes and metabolic syndrome
The growing prevalence of metabolic disorders creates an increasing demand for novel approaches to their prevention and therapy. Novel genetic diagnostic technologies are developed every year, which makes it possible to identify people who are at the highest genetic risk of diabetes, non-alcoholic f...
Main Authors: | A. I. Ershova, A. A. Ivanova, A. V. Kiseleva, E. A. Sotnikova, A. N. Meshkov, O. M. Drapkina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2022-01-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/3123 |
Similar Items
-
PLEYOTROPIC EFFECTS OF METFORMIN
by: L. Ju. Morgunov
Published: (2015-01-01) -
Biobank data for studying the genetic architecture of osteoporosis and developing genetic risk scores
by: E. A. Sotnikova, et al.
Published: (2022-01-01) -
Steatohepatitis in Children with Obesity
by: Alexander A. Zvyagin, et al.
Published: (2021-08-01) -
How to avoid statin hepatotoxicity in patients with obesity and liver disease? Focus on the combination of ursodeoxycholic acid and atorvastatin
by: O. N. Korneeva, et al.
Published: (2012-12-01) -
Assessment of polygenic risk of hypertension
by: A. S. Limonova, et al.
Published: (2023-01-01)